Publications by authors named "Jiro MINAMI"

Claim this Profile
C
Correction: Dual Inhibition of Canonical and Noncanonical NF-κB Pathways Demonstrates Significant Antitumor Activities in Multiple Myeloma.
Claire Fabre, Naoya Mimura, Kathryn Bobb, Sun-Young Kong, Güllü Gorgun, Jiro Minami

Clin Cancer Res· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful allogeneic peripheral blood stem cell transplantation for an aggressive variant of T-cell large granular-lymphocyte leukemia: A case report.
Kazuhito Suzuki, Kaichi Nishiwaki, Jiro Minami, Hidekazu Masuoka, Mitsuji Katori

Blood Cell Ther· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical significance of cancer-related fatigue in multiple myeloma patients.
Kazuhito Suzuki, Nobuyuki Kobayashi, Yoji Ogasawara, Takaki Shimada, Yuichi Yahagi, Jiro Minami

Int J Hematol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epstein-Barr Virus-associated Lymphoproliferative Disorder with Encephalitis Following Anti-thymocyte Globulin for Aplastic Anemia Resolved with Rituximab Therapy: A Case Report and Literature Review.
Kiyomi Mashima, Shingo Yano, Hiroki Yokoyama, Takeshi Saito, Tomohito Machishima, Jiro Minami

Intern Med· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical significance of granule-containing myeloma cells in patients with newly diagnosed multiple myeloma.
Kazuhito Suzuki, Shingo Yano, Kaichi Nishiwaki, Koji Sano, Takaki Shimada, Jiro Minami

Cancer Med· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of a Selective HSP90α/β Inhibitor and a RAS-RAF-MEK-ERK Signaling Pathway Inhibitor Triggers Synergistic Cytotoxicity in Multiple Myeloma Cells.
Rikio Suzuki, Shohei Kikuchi, Takeshi Harada, Naoya Mimura, Jiro Minami

PLoS One· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective and potent Akt inhibition triggers anti-myeloma activities and enhances fatal endoplasmic reticulum stress induced by proteasome inhibition.
Naoya Mimura, Teru Hideshima, Toshiyasu Shimomura, Rikio Suzuki, Hiroto Ohguchi, Jiro Minami

Cancer Res· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual inhibition of canonical and noncanonical NF-κB pathways demonstrates significant antitumor activities in multiple myeloma.
Claire Fabre, Naoya Mimura, Kathryn Bobb, Sun-Young Kong, Güllü Gorgun, Jiro Minami

Clin Cancer Res· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blockade of XBP1 splicing by inhibition of IRE1α is a promising therapeutic option in multiple myeloma.
Naoya Mimura, Mariateresa Fulciniti, Gullu Gorgun, Yu-Tzu Tai, Diana Cirstea, Jiro Minami

Blood· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two cases of mediastinal gray zone lymphoma.
Jiro Minami, Nobuaki Dobashi, Osamu Asai, Shingo Yano, Hiroshi Osawa

J Clin Exp Hematop· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid progression and unusual premortal diagnosis of mucormycosis in patients with hematologic malignancies: analysis of eight patients.
Shingo Yano, Jiro Minami, Kaichi Nishiwaki, Takaki Shimada, Nobuaki Dobashi

Int J Hematol· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[High-dose methotrexate followed by whole-brain irradiation for primary central nervous system lymphoma patients--a retrospective study in a single institute].
Noriko Usui, Nobuaki Dobashi, Shingo Yano, Yuichi Yahagi, Yutaka Takei, Jiro Minami

Gan To Kagaku Ryoho· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retrospective comparison of mobilization methods for autologous stem cell transplantation in multiple myeloma.
Hideki Nakasone, Yoshinobu Kanda, Tomoki Ueda, Kenji Matsumoto, Naomi Shimizu, Jiro Minami

Am J Hematol· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fractionated administration of gemtuzumab ozogamicin for refractory acute myeloid leukemia.
Yuichi YAHAGI, Noriko USUI, Yuko YAMAGUCHI, Nobuaki DOBASHI, Shingo YANO, Jiro MINAMI

Rinsho Ketsueki· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case of primary esophageal mucosa-associated lymphoid tissue lymphoma with a numerical abnormality of 18q21 detected by fluorescence in situ hybridization.
Shingo Yano, Noriko Usui, Nobuaki Dobashi, Yuichi Yahagi, Shinobu Takahara, Jiro Minami

Ann Hematol· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gemtuzumab ozogamicin (GO) in relapsed/refractory patients with acute myeloid leukemia.
Yuko Yamaguchi, Noriko Usui, Nobuaki Dobashi, Shingo Yano, Yuichi Yahagi, Jiro Minami

Gan To Kagaku Ryoho· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elevated serum levels of human matrix metalloproteinase-9 (MMP-9) during the induction of peripheral blood stem cell mobilization by granulocyte colony-stimulating factor (G-CSF).
Takeshi Saito, Noriko Usui, Osamu Asai, Nobuaki Dobashi, Shingo Yano, Jiro Minami

J Infect Chemother· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pseudo-Gaucher cell proliferation associated with myelodysplastic syndrome.
Takeshi Saito, Noriko Usui, Osamu Asai, Nobuaki Dobashi, Hiroyuki Ida, Jiro Minami

Int J Hematol· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term follow-up of autologous stem cell transplantation for patients with aggressive non-Hodgkin lymphoma who had bone marrow involvement at initial diagnosis in the pre-rituximab era.
Shingo Yano, Osamu Asai, Nobuaki Dobashi, Hiroshi Osawa, Yutaka Takei, Jiro Minami

Clin Lymphoma Myeloma· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Purification and characterization of C-terminal truncated forms of histone H2A in monocytic THP-1 cells.
Jiro Minami, Koji Takada, Katsuhiko Aoki, Yohta Shimada, Yutaka Okawa

Int J Biochem Cell Biol· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peripheral neuropathy caused by high-dose cytosine arabinoside treatment in a patient with acute myeloid leukemia.
Takeshi Saito, Osamu Asai, Nobuaki Dobashi, Shingo Yano, Hiroshi Osawa, Jiro Minami

J Infect Chemother· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Septic intramuscular embolism in a neutropenic patient with myelodysplastic syndrome accompanied by asymptomatic septic pulmonary emboli.
Shingo Yano, Noriko Usui, Osamu Asai, Nobuaki Dobashi, Hiroshi Osawa, Jiro Minami

Intern Med· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishment and some characteristics of epoxomicin (a proteasome inhibitor) resistant variants of the human squamous cell carcinoma cell line, A431.
Kiyoshi Ohkawa, Tadashi Asakura, Katsuhiko Aoki, Shun-Ichi Shibata, Jiro Minami

Int J Oncol· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Purification of N-terminally truncated histone H2A-monoubiquitin conjugates from leukemic cell nuclei: probable proteolytic products of ubiquitinated H2A.
Yutaka Okawa, Koji Takada, Jiro Minami, Katsuhiko Aoki, Hirohiko Shibayama

Int J Biochem Cell Biol· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis